Fluid-jet medicament delivery
A method of applying an orally-ingestible medicament to an orally-ingestible carrier comprising the steps of controlling a relative position between a fluid ejector and the carrier, and ejecting a plurality of drops of solution onto the carrier, wherein the plurality of drops includes a desired therapeutic quantity of the orally-ingestible medicament.
This application is a continuation-in-part of U.S. application Ser. No. 10/028,450, filed Oct. 24, 2001.BACKGROUND
1. Field of the Invention
The present disclosure relates to fluid-jet medicament delivery. More particularly, the present disclosure relates to applying precise doses of medicament onto an edible sheet using fluid-jet technology.
2. Description of the Art
Oral administration of pharmaceuticals is one of the most widely used methods to provide effective therapy for a variety of illnesses. Many powdered medications are typically administered orally to a person in a dosage form such as tablets or capsules, while still others are in liquid form. The release of orally administered medications falls into two broad categories, buccal or sublingual administration, and oral dissolution. For example, enteric coated tablets that release the medication in the intestinal tract of the patient. Further, many individuals suffer from chronic health problems that require the regular administration of medicaments. Diseases such as diabetes, allergies, epilepsy, heart problems, AIDS, and even cancer requires the regular delivery of precise doses of medicaments if patients are to survive over long periods of time. Such chronic treatment creates the need to regularly obtain additional medication. This can be extremely troublesome for those patients that lack the mobility to easily travel to a pharmacist to refill medications, such as the elderly and infirm. Thus, a method and a dosage form that provides the ability to make custom doses, outside of the large pharmaceutical manufacturing plants, is desirable.
Most pharmaceuticals involve dosage units in the microgram to milligram range of the purified active ingredient or ingredients. Thus, many pharmaceutical doses in tablet or liquid form are made in formulations of a predetermined quantity of pharmaceutical units in each dose. Such pharmaceutical doses are frequently available in fixed different strengths, such as 50 mg, 100 mg, etc.
Unfortunately, such conventional oral dosage forms suffer from a number of disadvantages. Typically, to effectively handle and dispense small doses a considerable amount of adjuvant material must be added in order that the final dosage form is of a manageable size. Thus, typical methods for manufacturing include the mixing of the pure drug with various other substances commonly referred to as excipients or diluents that are therapeutically inert and acceptable by regulatory bodies, such as the FDA. Excipients may also protect the drug from deterioration by oxidation, humidity, and light. Palatability can be improved through the addition of flavorants and identification by use of colorants. This mixing process often requires the use of sophisticated, complex expensive machinery. Certain excipients may be needed to improve the flowability of the drug and diluents through the mixing machinery. Therefore, a method and dosage form that reduces the mixing of the active drug with other substances, and utilizes less complex and expensive machinery would also be desirable.
These therapeutically inactive or inert materials also have the disadvantage that each such material must be evaluated before use in terms of potential incompatibilities with the medicaments present. For example, some of these materials, such as lubricants or disintegrants, may present problems concerning the bioavailability of the active ingredient. Further, the certification of new drugs is a lengthy and costly process involving animal studies followed by chemical trials to establish both the efficacy and safety of the new drug. Because a pharmaceutical's characteristics may be affected by changes in manufacturing and/or packaging, the approval process limits the approval to a particular manufacturing and packaging process. Thus, the ability to rapidly and easily change dosage units is extremely limited in conventional pharmaceutical manufacturing processes.
Drugs with a narrow therapeutic range must also be precisely dosed. If the patient falls below the range, the desired effect will not occur. However, if the patient is above the range then the risk of toxic effects increases. Clinicians assume the dose units manufactured are uniform and that generic equivalents have equal bioavailability. The many FDA generic formulation rejections and recalls for pharmaceuticals that have too high or low of a drug level, however, are evidence that accuracy and precision are still challenges for pharmaceutical manufacturing.
The ability to easily make a custom dose using tablets or capsules utilizing current technology is also difficult. It is virtually impossible to split or divide a capsule to decrease the dose administered requiring that the smallest dose be predetermined. Further, in the case of tablets a patient or pharmacist may often encounter difficulty in splitting or dividing even relatively large tablets that have a notch or groove at a predetermined breaking point to form a lower dosage unit. The splitting or breaking often results in fragments of unequal size. Thus, a method and dosage form that allows for variable doses to be formed outside the pharmaceutical manufacturing plant is desirable.BRIEF DESCRIPTION OF THE DRAWINGS
The present invention advantageously uses the multi-drop deposition capability of a fluid-jet ejection system to dispense medicaments on an ingestible carrier such as an ingestible sheet. Although one embodiment describes the use of a thermally activated fluid-jet ejection cartridge to dispense medications in the form of drops on an ingestible media, other methods of activating fluid-jet ejection, such as piezoelectric or acoustic activation, may also be used in the present invention. The fluid ejection system of the present disclosure includes a drop-on-demand type fluid dispenser. The present disclosure provides greater control of the drug dose than a typical diluting and mixing apparatus by producing precise and repeatable doses onto an ingestible carrier. Another feature of the present invention is the ability to dispense multiple different pharmaceuticals in varied quantities onto an ingestible carrier.
For purposes of this description, the term “medicament” shall mean a substance that treats or prevents or alleviates a disease or illness and/or the symptoms of the disease or illness. An example of a medicament is a pharmaceutical substance, such as a drug. The term “medicament” can be used to refer to such a substance in pure form, a mixture of the substance with other substances, and/or a solution including the substance. An “orally-ingestible medicament” is a medicament intended for intake into the digestive track via the mouth, as opposed to a medicament that is intended to be injected or surgically implanted. An orally-ingestible medicament may be configured to be digested and/or otherwise act in one or more of the mouth, throat, stomach, intestines, or any other portion of the alimentary canal.
The substrate (not shown), the nozzle layer 126, nozzles 124, and a flexible circuit 125 form what is generally referred to as an ejector head 122. In other embodiments the ejector head 122 includes the substrate (not shown), the nozzle layer 126 and the nozzles 124. The nozzle layer 126 contains one or more nozzles 124 through which fluid, that is contained in a chamber around the fluid ejectors, is ejected by activation of the fluid ejectors (not shown) located in close proximity to the nozzles 124. Each activation of a fluid ejector results in the ejection of a precise quantity of fluid in the form of a fluid drop; thus, the number of activations of the fluid ejector controls the number of drops ejected. For more information on drop formation see for example Jaime H. Bohorquez et al., Laser-Comparable Inkjet Text Printing, Hewlett-Packard Journal, vol. 45, no. 1, pg. 9-17, February 1994; or William A. Buskirk et al., Development of a High Resolution Thermal Inkjet Printhead, Hewlett-Packard Journal, vol. 39, no. 5, pg. 55-61, October 1988.
The fluid ejection cartridge 102 described in the present invention can reproducibly and reliably eject drops in the range of from about ten femto-liters to about ten micro-liters depending on the parameters of the fluid ejection cartridge such as the size and geometry of the chamber around the fluid ejector, the size and geometry of the fluid ejector, and the size and geometry of the nozzle. Thus, the present invention has the ability to accurately dispense a medicament solution with a part per million to a part per billion accuracy. This is particularly advantageous when dispensing expensive medicaments, such as certain hormones, antibiotics, and medicaments derived from some natural products in scarce supply. The accuracy and precision is advantageous when dispensing concentrated substances with high potency. In addition, a further advantage of utilizing the fluid ejection cartridge 102 of the present invention is a reduction, to less than one percent by weight, in the amount of excess medicament that is dispensed to assure proper label dosage. In other words, medicament can be accurately applied to a carrier in the form of a plurality of closely sized drops, which include substantially equal amounts of medicament. By controlling the number of drops that are applied, the total amount of medicament can be controlled. As used herein, “target dose” shall mean the exact amount of medicament that is to be placed onto a carrier, and “therapeutic quantity” is a range of acceptable doses that includes the target dose. This embodiment is also advantageous for utilizing a mixture of the medicament and an ingestible ink contained in the fluid reservoir 128.
Fluid ejection cartridge 102, can utilize a method of creating discrete sized drops that are independently ejected from a particular nozzle utilizing a particular fluid ejector while maintaining a narrow drop volume distribution. In addition, the narrow drop volume distribution can be maintained over multiple nozzles each having a separate fluid ejector and fired independently or simultaneously. Such a cartridge can be characterized by a very narrow distribution of drop volumes and may have anywhere from a 2×, 3× or even more narrower drop volume distribution than conventional fluid ejector devices such as hydraulic, air assisted, or ultrasonic nozzles that form a spray of fluid having varying drop sizes. The range in drop volume is generally within 10 percent of the targeted or specified value and under steady state conditions can be within about 6 percent or less of the targeted value. Thus, a medicament can be accurately dispensed with a part per million to a part per billion accuracy.
The nozzle layer 126 may be formed of metal, polymer, glass, or other suitable material such as ceramic. Preferably, the nozzle layer 126 is formed from a polymer such as polyimide, polyester, polyethylene naphthalate (PEN), epoxy, or polycarbonate. In an alternate embodiment, the nozzle layer 126 is formed from a metal such as a nickel base enclosed by a thin gold, palladium, tantalum, or rhodium layer. Preferably, the components of the ejector head 122 and the fluid reservoir are formed of materials that are inert to the medicament and/or the ingestible ink which are to be dispensed therefrom. Thus, inert materials such as glass, ceramic, stainless steel, noble metals, and polymers inert to the medicament are preferred.
The fluid is selectively expelled from the one or more of the nozzles 124 by electrical signals communicated through electrical contacts 130 and associated conductive traces 132 disposed on the flexible circuit 125. In the preferred embodiment, the flexible circuit 125 is typically bent around an edge of the fluid ejection cartridge 102 and secured. The electrical traces 132 are routed from the electrical contacts 130 to bond pads on the substrate (not shown) to provide electrical connection for the fluid ejection cartridge 102. Thus, by communicating the proper electrical signal through the electrical contacts 130 a fluid ejector is activated the appropriate number of times to eject a predetermined number of drops.
An information storage element 133 is disposed on cartridge 102. Preferably, the information storage element 133 is coupled to a flexible circuit such as the flexible circuit 125 as shown in
When the fluid ejection cartridge 102 is either inserted into, or utilized in, a dispensing system the information storage element 133 is electrically coupled to a controller that communicates with the information storage element 133 to use the information or parameters stored therein. However, other forms of information storage can also be utilized for the information storage element 133, such as a bar code or other device that allows storage of information. Further, the information storage element 133 can be mounted elsewhere on or within the body of the fluid ejection cartridge 102 with appropriate contacts and electrical connections to access the storage element depending on the particular application. In addition, the information storage element 133 can also be placed on an off-axis container utilized with semi-permanent ejector heads or cartridges.
The information storage element 133 may contain information such as the particular medicament or other material contained in the fluid reservoir 128; the quantity of material remaining in the fluid reservoir 128 based on the number of drops dispensed or the number of times the fluid ejector has been activated. Other information can include the date of manufacture, inspection dates, quality control information, dispensing system parameters, and customer/patient information.
The fluid ejection cartridge 102, or more preferably a set of individual fluid ejection cartridges 102 and 103, capable of ejecting drops of medicament and/or ingestible ink or a combination thereof from ejector heads 122 and 123 are held within a carriage 111, as illustrated in a perspective view in
An alternate embodiment of the present invention where a carriage 111′ contains an image acquisition system 150 is shown in
The image acquisition system 150 also contains, a camera and light source, controller 153 that is preferably coupled to a drop-firing controller 214 as shown in
In addition to capturing images of either the medicament or ingestible ink or other material dispensed on the ingestible sheet the image acquisition system 150 can also be utilized to capture images of information that has been placed on an ingestible sheet prior to deposition of the medicament or ingestible ink. Examples of such information are the composition of the ingestible sheet or results of quality control testing; data on compatibility with the medicaments, i.e. whether the ingestible sheet is compatible or incompatible with medicament being dispensed; patient information such as height, weight, name, age, prescribed dose etc.; expiration dates, temperature and/or humidity sensors, indicating that the ingestible sheet is no longer effective or it has been exposed to an extreme which could hinder its effectiveness. Although the image acquisition system 150, as depicted in
The essential parts of a medicament dispensing system 200 according to an embodiment of the present invention is shown in a block diagram in
Under control of the drop firing controller 214 and a position controller 218, the carriage 111 scans across the ingestible sheet 204, and fluid drops are selectively ejected from fluid ejectors disposed within the fluid ejection heads of the set of fluid ejection cartridges 102 and 103 onto the ingestible sheet 204. The power to activate the fluid ejectors is supplied by a power supply 215. The drops are ejected to form predetermined dot matrix patterns, forming both the pharmaceutical dose from the cartridge containing the medicament, and images or alphanumeric characters from the cartridge containing the ingestible ink.
Rasterization of the data can occur in a host computer such as a personal computer or PC (not shown) prior to the rasterized data being sent, along with the system control commands, to the system, although other system configurations or system architectures for the rasterization of data are possible. This operation is under control of system driver software resident in the system's computer. The system interprets the commands and rasterized data to determine which drop ejectors to fire. An arrow in
As can be appreciated from a preferred embodiment shown in
When the fluid ejection cartridges 102, 103 reach the end of their travel at an end of a fluid ejection swath on the ingestible sheet 204, the ingestible sheet 204 is conventionally incrementally advanced by the position controller 218 and the platen motor 216. Once the fluid ejection cartridges have reached the end of their traverse in the X direction on the slide bar 213 or similar support mechanism, they are either returned back along the slide bar 213 while continuing to eject fluid or returned without ejecting. The ingestible sheet 204 may be advanced by an incremental amount equivalent to the width of the fluid-ejecting portion of the fluid-ejecting head or some fraction thereof related to the spacing between the nozzles. Control of the ingestible sheet 204, positioning of the fluid ejection cartridge, and selection of the correct fluid ejectors for creation of both the medicament dose and the image or character written is determined by the position controller 218 and the drop-firing controller 214. The controllers may be implemented in a conventional electronic hardware configuration and provided operating instructions from conventional memory 219.
The medicament dispensing system 200 can also contain a heater 221 coupled to a heater controller 220 as shown in
A perspective view of an alternate embodiment of the present invention where the medicament dispensing system 200 includes an ingestible sheet tray 299 is shown in
The apparatus described above makes unique use of an automated fluid ejecting device, having at least one medicament supply in a reservoir or chamber and at least one, and preferably, a plurality of fluid ejectors in an array, each ejector dispensing a precise volume of fluid in essentially individual droplets on each activation of the fluid ejector. This arrangement enables the quantity of the medicament dispensed to be varied in a specified area of the ingestible sheet thereby enabling either custom, or a wide range of doses to be more easily prepared. The apparatus or system as depicted in
A cross-sectional view of an alternate embodiment of the present invention where a fluid ejection cartridge 302 includes three fluid reservoirs 327, 328, and 329 contained within a cartridge body 334 is shown in
Attached to the substrate 336 is a firing chamber layer 344 that defines the volume around each fluid ejector. Attached to the firing chamber layer 344 is a nozzle layer 326 that contains three groups of nozzles 324, 324′ and 324″. The fluid will flow from the three fluid reservoirs 327, 328, and 329 through the three fluid filters 340, 341, and 342 into the three fluid output ports 337, 338, and 339 through the substrate 336. A firing chamber layer 344 includes fluid channels (not shown) and a firing chamber (not shown) formed into the layer that feeds fluid to the ejectors 346, 346′ and 346″. Upon appropriate activation, the ejectors 346, 346′ and 346″ initiate the ejection of fluid out of the fluid ejection cartridge 302 through the three groups of nozzles 324, 324′ and 324″. Preferably, each group of nozzles is in a column and more preferably in staggered columns, however other patterns, such as circular patterns can also be utilized. This embodiment is particularly advantageous when the user desires a self-contained cartridge or integral replaceable unit containing the medicament, the ingestible ink, and a protective coating that is dispensed over the dispensed medicament. This embodiment is also advantageous when the user has three compatible medicaments that can be dispensed on the same sheet.
Although the properties of the ingestible sheets used in accordance with the present invention depend both on the particular medicament being dispensed and on the particular materials utilized in the sheet, it is generally preferable that the sheets are safely edible or ingestible, and do not have an objectionable “feel” in the mouth. In addition, the sheets preferably dissolve or degrade in body fluids and/or enzymes. However, the sheets can be made of non-degradable materials that are readily eliminated by the body. Preferably the sheets are hydrophilic and readily disintegrate in water and more preferably the dissolution or disintegration of the sheets is enhanced at the pH of the fluids in the stomach or upper intestine. Further, ingestible sheets that minimize unintended interactions with the medicament dispensed on the sheets and sheets that minimize the release of any sheet component that would cause unintended interactions with the medicament upon dissolution of the sheet, are also desirable.
Additional properties of the ingestible sheet that are desirable are the ability to remain stable over extended periods of time, at elevated temperatures, and at high or low levels of relative humidity. In addition, it is also preferable that the ingestible sheets are generally a poor medium for the growth of microorganisms to reduce spoilage. Further, ingestible sheets that possess reasonable mechanical properties such as tensile strength and tear strength are desirable to allow the sheets to be processed through the various steps of fabrication of the final dosage form using methods such as are recognized in the art.
Ingestible sheets that can be utilized in the present invention can be one or a mixture of organic film formers generally classified into two broad categories, i.e. polymeric and paper. Examples of such film formers are starch (i.e. both natural and chemically modified) and glycerin based sheets with or without a releasable backing. Other examples include, proteins such as gelatin, cellulose derivatives such as hydroxypropylmethylcellulose and the like; other polysaccharides such as pectin, xanthan gum, guar gum, algin and the like; synthetic polymers such as polyvinyl alcohol, polyvinylpyrrolidone and the like. Examples of ingestible sheets or edible films that can be utilized are those that are based on milk proteins, rice paper, potato wafer sheets, and films made from restructured fruits and vegetables.
In particular, sheets or films made from restructured fruits and vegetables are advantageous were it is desirable to mask or modify the taste or smell of the medicament being delivered. Further, these restructured fruit and vegetable films also provide a convenient approach to encourage children to take various medications as well as providing a more pleasing and varied taste for various medications taken by adults. For more information on restructured fruit and vegetable films, see for example U.S. Pat. No. 5,543,164 and U.S. Pat. No. 6,027,758.
Dispensing the medicament on an ingestible sheet containing a water-expandable foam is preferable for those applications desiring rapid release of the medicament once ingested. Examples of such materials are an oxidized regenerated cellulose commercially available from Johnson and Johnson under the trademark SURGICEL®, and a porcine derived gelatin powder commercially available from Pharmacia Corporation under the trademark GELFOAM®.
The form of the ingestible sheet that can be utilized in the present invention can be any of the forms generally recognized in the art such as those used for paper, cardboard or polymeric films. The ingestible sheet or roll preferably is uniform in thickness and in width. Although the thickness of the ingestible sheet will depend on the particular medicament being dispensed, the particular ingestible sheet being utilized, and the particular method of manufacture used; the thickness of the ingestible sheet preferably ranges from about 10 to about 350 microns and more preferably from about 25 to about 100 microns thick.
The dosage forms produced in accordance with the present invention are eminently suited to span the range of production from individualized doses made in a home or hospital environment to the high speed high volume production in a pharmaceutical manufacturing environment. Thus, the particular width and length will not only depend on both the particular medicament being dispensed and the particular ingestible sheet being utilized, but more particularly on the particular method of manufacture used. Thus, the ingestible sheet can be in roll or individual sheet forms with widths varying from approximately one centimeter to several meters, and lengths from a few centimeters to several thousand meters, although other lengths and widths can also be utilized.
An embodiment of an ingestible sheet that is preferable for both high speed high volume manufacturing as well as for custom, individualized dispensing is illustrated in a perspective view in
Preferably, after the medicament is dispensed on the dosage form 405 the user or system separates the dosage form 405 from the dosage form 405′ by tearing, by cutting along the perforations 447, or by punching out the dispensed areas of the sheet. The user or system can also separate the dosage form 405 from the dosage form 405′ before dispensing of the medicament. This embodiment is particularly advantageous for systems such as those that have fixed fluid ejection cartridges; however, it can also be utilized in other systems as well. Preferably, the ejector head is approximately the width of the ingestible sheet 404 and the platen (not shown) moves the ingestible sheet in the direction of arrow 448 allowing both the dispensed dose of medicament as well as the appropriate characters or symbols utilizing the ingestible ink to be formed.
An alternate embodiment of an ingestible sheet that can also be used for custom, individualized pharmaceutical doses is shown in a plan view in
An embodiment of a method for generating a dosage form where the medicament is dispensed onto the ingestible sheet is shown in a cross-sectional view in
An alternate embodiment of the present invention where the process used for generating a dosage form includes a barrier material deposited over the medicament is shown in a cross-sectional view in
An alternate embodiment of the present invention where the process used for generating a dosage form includes ingestible ink deposited over the medicament is shown in a cross-sectional view in
An alternate embodiment of the present invention where the process used for generating a dosage form includes deposition of more than one medicament onto the ingestible sheet 604′ is shown in a cross-sectional view in
After the second medicament has been dispensed, a second barrier is then formed over the deposits 656, 656′ and 656″ forming barrier deposits 658, 658′ and 658″ forming dosage form 608. Preferably the second barrier material is the same as the first, however, depending on the properties and compatibilities of the first and second medicaments as well as the first barrier material the second barrier material may be different from the first barrier material. Although
An alternate embodiment of the present invention of a process for manufacturing a dosage form containing more than one medicament is shown in a perspective view in
An alternate embodiment of the present invention of a process for manufacturing a dosage form containing more than one medicament is shown in a plan view in
As noted above an expandable foam may be desirable for the rapid release of a medicament once ingested, however, some applications may want to vary the amount of the medicament released over time. An advantage of the present invention is the ability to make dosage forms that can vary the amount of medicament or drug released over time as shown in
As the ingestible sheet 804 dissolves the radius of the coiled dosage form 805 decreases, resulting in a smaller surface area, thus the amount of medicament released can be varied or maintained constant. For example as shown in
A perspective view of an alternate embodiment of the present invention where repeat dosages are formed is shown in
A cross-sectional view of an alternate embodiment of the present invention where a dosage form 1005 is encapsulated in a tablet 1079 is shown in
Depending on the desired pharmacokinetic characteristics of the medicament dispensed on the ingestible sheet 1004, the excipient formulation may be similar to the ingestible sheet 1004 or one may select excipients that are dissimilar to the ingestible sheet to obtain tabletting or pharmacokinetic characteristics unlike the ingestible sheet 1004. For example microcrystalline sugar (97% sucrose and 3% maltodextrin) or cellulose, calcium phosphate, and sodium carboxymethylcellulose can be used with a cellulosic-based ingestible sheet. Sugars and corn, wheat, or rice starches can be used with starch-based ingestible sheets. Whereas silica added to improve flowability, stearates for lubrication, and guar gum or gelatin as binders are examples of dissimilar materials.
A preferable excipient formulation for direct compression tabletting of a dosage form made from an ingestible sheet which does not include the weight of the ingestible sheet nor the weight of the medicament dispensed is: about 70 weight percent lactose, about 25 weight percent microcrystalline cellulose, about 2 weight percent di-calcium phosphate dihydrate, 2 weight percent sodium carboxymethylcellulose, about 0.3 weight percent fumed silica and about 0.5 weight percent magnesium stearate. However, excipient ranges in formulations for direct compression tabletting of a dosage form made from an ingestible sheet which does not include the weight of the ingestible sheet nor the weight of the medicament dispensed are 0 to about 80 weight percent sugar, 0 to about 25 weight percent microcyrstalline cellulose, 0 to about 90 weight percent calcium phosphate, about 5 to about 25 weight percent starch, about 1 to about 2 weight percent sodium carboxymethylcellulose, about 0.2 to about 0.3 weight percent silica and about 0.5 to about 1 weight percent magnesium stearate can also be utilized.
In addition to improve adhesion between the excipient powder formulation and the ingestible sheet the excipient formulation can be modified by adding natural or synthetic polymers such as proteins, carboxymethylcellulose, polyvinylacetate, gelatins, or dextrins can be utilized to improve the adhesive properties of the excipient powder. It is also contemplated that an ingestible adhesive can be dispensed between the two die chambers prior to applying pressure to form the tablet. For example, a monomeric methyl or ethylcyanoacrylate type adhesive can be utilized. Alternatively, the ingestible sheet 1004 of the dosage form 1005 can be perforated to allow greater contact area between excipient powder 1078 contained in the upper die chamber 1076 and the lower die chamber 1074 or the dosage form 1005 can be formed in the shape of a ring containing an area in the center of the dosage form 1005 that allows the excipient powder in the two chambers to bond.
The process described above for compression tabletting of an ingestible sheet containing a medicament is advantageous over conventional tabletting in that the number of mixing steps can be reduced as well as the need to assure thorough mixing of the excipient with the pharmaceutical material to ensure proper dilution. In addition, flowability and drying criteria of the excipient formulation can also be relaxed.
An exemplary system 1100 for the interactive dispensing of a medicament on an ingestible sheet is shown as a schematic diagram in
The system 1100 having the processor 1180, display device 1184, and storage device 1186 is advantageous over current methods of forming pharmaceutical doses in that it allows a user such as a doctor or pharmacist to generate variable doses as well as custom doses in the convenience of a hospital, pharmacy, or home environment. Further, such a system can also be utilized as a point of sale machine, in such locations as a pharmacy or a supermarket, to allow customers to create variable or custom doses of vitamins, nutritional supplements, or other over-the-counter medications.
In addition, the system 1100 also includes a user interface 1188 or signal receiver that is coupled to the processor 1180 and is also coupled via communication channel 1193 to an external communication network 1190 as shown in
The provider system 1192 includes a provider processor 1181, coupled to a provider display 1185, a provider storage device 1187, and a provider interface 1189. The provider interface 1189 is coupled via provider channel 1194 to the external communication network 1190. The provider system 1192 is utilized, for example, by a health care provider such as a doctor, a pharmacist, a nurse, appropriate insurance personnel, or other appropriate health care professional. Although
An exemplary embodiment of an interactive method for generating a dosage form where the medicament is dispensed onto the ingestible sheet is shown as flow diagrams in
A more detailed view of the various steps associated with the loading step 1200 is shown in
A more detailed view of the various steps associated with the reading step 1210 is shown as a flow diagram in
A more detailed view of the various steps associated with the requesting step 1220 is shown as a flow diagram in
A more detailed view of the various steps associated with the specifying step 1230 is shown as a flow diagram in
A more detailed view of the various steps associated with the verifying step 1240 is shown as a flow diagram in
A more detailed view of the various steps associated with dosing of the medicament on the ingestible sheet in step 1250 is shown as a flow diagram in
A more detailed view of the various steps associated with printing information on the ingestible sheet, in step 1260, is shown as a flow diagram in
The present invention can advantageously reduce the number of therapeutically inactive materials, the number of dilutions, and the number of mixings in the manufacture of unit dosage forms. In addition, the medicament cartridge and the medicament dispensing system of the present invention provides for the custom dispensing of pharmaceutical unit dosage forms where the type of pharmaceutical and the quantity of the selected drug can be easily varied to meet a specific prescription. The medicament cartridge and the medicament dispensing system of the present invention provides the ability of dispensing multiple, different pharmaceuticals in varied, selected quantities to a single receiving medium thus simplifying the taking of drugs, especially combinations of different drugs by providing multiple drugs in one dose.
1. A method of applying an orally-ingestible medicament to an orally-ingestible carrier, the method comprising:
- controlling a relative position between a fluid ejector and the carrier; and
- ejecting a plurality of drops of solution onto the carrier, wherein the plurality of drops includes a desired therapeutic quantity of the orally-ingestible medicament.
2. The method of claim 1, wherein each of the plurality of drops has substantially the same volume as each other drop of the plurality of drops.
3. The method of claim 2, wherein each of the plurality of drops has a volume at most 10% different than a volume of each other drop of the plurality of drops.
4. The method of claim 2, wherein each of the plurality of drops has a volume at most 6% different than a volume of each other drop of the plurality of drops.
5. The method of claim 2, wherein each of the plurality of drops includes substantially equal amounts of orally-ingestible medicament.
6. The method of claim 5, wherein each of the plurality of drops has an amount of orally-ingestible medicament at most 10% different than an amount of orally-ingestible medicament of each other drop of the plurality of drops.
7. The method of claim 5, wherein each of the plurality of drops has an amount of orally-ingestible medicament at most 6% different than an amount of orally-ingestible medicament of each other drop of the plurality of drops.
8. The method of claim 1, wherein ejecting a plurality of drops includes ejecting a number of drops selected to yield the desired therapeutic quantity of the orally-ingestible medicament.
9. The method of claim 1, wherein the desired therapeutic quantity is within a range no more than 1% greater or less than a target dose.
10. The method of claim 1, further comprising printing information onto the orally-ingestible sheet.
11. The method of claim 10, wherein printing includes printing the information onto the orally-ingestible sheet in a machine detectable form.
12. The method of claim 10, wherein printing includes printing the information onto the orally-ingestible sheet in a human-perceptible form.
13. The method of claim 1, further comprising sealing the orally-ingestible medicament on the orally-ingestible sheet.
14. The method of claim 13, wherein sealing includes activating a fluid ejector to eject a barrier component fluid over the orally-ingestible medicament.
15. An edible dosage form produced by the method of claim 1.
16. A method of applying an orally-ingestible medicament on an orally-ingestible sheet, comprising:
- advancing the orally-ingestible sheet to a dispense position; and
- activating a fluid ejector to eject the orally-ingestible medicament onto the orally-ingestible sheet.
17. The method of claim 16, further comprising printing information onto the orally-ingestible sheet.
18. The method of claim 17, wherein printing includes printing the information onto the orally-ingestible sheet in a machine detectable form.
19. The method of claim 17, wherein printing includes printing the information onto the orally-ingestible sheet in a human-perceptible form.
20. The method of claim 17, wherein printing includes ejecting an orally-ingestible ink from at least one ink ejector fluidically coupled to an ink reservoir onto the orally-ingestible sheet.
21. The method of claim 16, wherein activating includes activating the fluid ejector to eject a predetermined number of ejections of the orally-ingestible medicament.
22. The method of claim 16, further comprising sealing the orally-ingestible medicament on the orally-ingestible sheet.
23. The method of claim 21, wherein sealing includes activating a barrier fluid ejector to eject a barrier component fluid over the orally-ingestible medicament.
24. An edible dosage form produced by the method of claim 16.
25. A method of applying an orally-ingestible medicament on an orally-ingestible sheet, comprising:
- receiving a fluid ejection cartridge into a fluid dispensing system, the cartridge holding a mixture of an orally-ingestible ink and an orally-ingestible medicament;
- advancing the orally-ingestible sheet to a dispense position; and
- printing a user message on the orally-ingestible sheet using the mixture of the orally-ingestible ink and the orally-ingestible medicament.
26. An edible dosage form produced by the method of claim 25.
27. A method of manufacturing an orally-ingestible dose, comprising:
- advancing an orally-ingestible sheet having at least one dosage region to a dispense position; and
- activating a fluid ejector to eject a two-dimensional array of an orally-ingestible medicament onto the dosage region of the orally-ingestible sheet, wherein the dosage region includes a first edge and a second edge, and wherein a density of the two-dimensional array of the orally-ingestible medicament varies between the first edge and the second edge, forming a two-dimensional gradient of orally-ingestible medicament.
28. The method of claim 27, further comprising coating a deposited array of ingestible medicament with an ingestible coating material.
29. The method of claim 28, wherein coating the deposited array includes activating a second fluid ejector to eject an ingestible barrier component fluid over the deposited array of ingestible medicament.
30. An edible dosage form produced by the method of claim 27.
31. A method of manufacturing an orally-ingestible dosage form, comprising:
- advancing an orally-ingestible sheet having at least one dosage region to a dispense position;
- activating a fluid ejector to eject a first two-dimensional array of an orally-ingestible medicament onto the dosage region of the orally-ingestible sheet;
- dispensing an orally-ingestible barrier layer on the first two-dimensional array of orally-ingestible medicament; and
- activating the fluid ejector to eject a second two-dimensional array of orally-ingestible medicament on the orally-ingestible barrier layer, thus forming a three-dimensional array of orally-ingestible medicament on the orally-ingestible sheet.
32. An edible dosage form produced by the method of claim 31.
Filed: Jan 31, 2005
Publication Date: Jun 16, 2005
Inventors: Brian Lee (Corvallis, OR), Steven Steinfield (San Diego, CA), Winthrop Childers (San Diego, CA), Mark Van Veen (Cardiff by the Sea, CA), Mohammad Samii (La Jolla, CA)
Application Number: 11/048,368